Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia: A preliminary study

Ramesh Eluri, Chitta Paul, Richard Roemer, Orest Boyko

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Magnetic resonance spectroscopy (MRS) is a non-invasive functional imaging technique that can measure various brain tissue metabolites such as N-acetylaspartate (NAA), choline (Cho), creatine-phosphocreatine (Cr), myo- inositol (mI) and other metabolites. Morphological studies have indicated the pons and cerebellum as possible sites of abnormal functioning in schizophrenic patients. This study examines schizophrenic patients for the presence of abnormalities in proton MRS (1H-MRS) measured metabolites in two regions of the posterior fossa. Twelve schizophrenic patients and eight non- schizophrenic control subjects were studied by measuring the ratios of NAA/Cr, Cho/Cr and mI/Cr from 1H-spectra obtained from the pons and right or left cerebellum using an integrated MRI/MRS protocol. Spectra were obtained from a voxel in the pons and voxels from the left and/or right lateral cerebellum. Data were analyzed in the absorption mode and fitted to Lorentzian lineshapes using a Marquart algorithm. Significantly lower NAA/Cr ratios were found in the pons of schizophrenic patients than in the control subjects, but not in the cerebellum. This study is the first to measure brain tissue metabolites using 1H-MRS in the pons and cerebellum of schizophrenic patients. Significant alterations of 1H-MRS metabolites may suggest the involvement of the posterior fossa as a part of the pathological substrate underlying schizophrenia.

Original languageEnglish (US)
Pages (from-to)17-26
Number of pages10
JournalPsychiatry Research - Neuroimaging
Volume84
Issue number1
DOIs
StatePublished - Nov 9 1998

Fingerprint

Phosphocreatine
Pons
Creatine
Cerebellum
Schizophrenia
Magnetic Resonance Spectroscopy
Inositol
Choline
Brain
Proton Magnetic Resonance Spectroscopy
N-acetylaspartate

Keywords

  • Creatine-phosphocreatine
  • Magnetic resonance imaging
  • N-Acetylaspartate
  • Posterior fossa

ASJC Scopus subject areas

  • Neuroscience (miscellaneous)
  • Radiology Nuclear Medicine and imaging
  • Psychiatry and Mental health

Cite this

Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia : A preliminary study. / Eluri, Ramesh; Paul, Chitta; Roemer, Richard; Boyko, Orest.

In: Psychiatry Research - Neuroimaging, Vol. 84, No. 1, 09.11.1998, p. 17-26.

Research output: Contribution to journalArticle

@article{9ea6ed12de944a8cba984a992c31d539,
title = "Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia: A preliminary study",
abstract = "Magnetic resonance spectroscopy (MRS) is a non-invasive functional imaging technique that can measure various brain tissue metabolites such as N-acetylaspartate (NAA), choline (Cho), creatine-phosphocreatine (Cr), myo- inositol (mI) and other metabolites. Morphological studies have indicated the pons and cerebellum as possible sites of abnormal functioning in schizophrenic patients. This study examines schizophrenic patients for the presence of abnormalities in proton MRS (1H-MRS) measured metabolites in two regions of the posterior fossa. Twelve schizophrenic patients and eight non- schizophrenic control subjects were studied by measuring the ratios of NAA/Cr, Cho/Cr and mI/Cr from 1H-spectra obtained from the pons and right or left cerebellum using an integrated MRI/MRS protocol. Spectra were obtained from a voxel in the pons and voxels from the left and/or right lateral cerebellum. Data were analyzed in the absorption mode and fitted to Lorentzian lineshapes using a Marquart algorithm. Significantly lower NAA/Cr ratios were found in the pons of schizophrenic patients than in the control subjects, but not in the cerebellum. This study is the first to measure brain tissue metabolites using 1H-MRS in the pons and cerebellum of schizophrenic patients. Significant alterations of 1H-MRS metabolites may suggest the involvement of the posterior fossa as a part of the pathological substrate underlying schizophrenia.",
keywords = "Creatine-phosphocreatine, Magnetic resonance imaging, N-Acetylaspartate, Posterior fossa",
author = "Ramesh Eluri and Chitta Paul and Richard Roemer and Orest Boyko",
year = "1998",
month = "11",
day = "9",
doi = "10.1016/S0925-4927(98)00043-2",
language = "English (US)",
volume = "84",
pages = "17--26",
journal = "Psychiatry Research - Neuroimaging",
issn = "0925-4927",
publisher = "Elsevier Ireland Ltd",
number = "1",

}

TY - JOUR

T1 - Single-voxel proton magnetic resonance spectroscopy of the pons and cerebellum in patients with schizophrenia

T2 - A preliminary study

AU - Eluri, Ramesh

AU - Paul, Chitta

AU - Roemer, Richard

AU - Boyko, Orest

PY - 1998/11/9

Y1 - 1998/11/9

N2 - Magnetic resonance spectroscopy (MRS) is a non-invasive functional imaging technique that can measure various brain tissue metabolites such as N-acetylaspartate (NAA), choline (Cho), creatine-phosphocreatine (Cr), myo- inositol (mI) and other metabolites. Morphological studies have indicated the pons and cerebellum as possible sites of abnormal functioning in schizophrenic patients. This study examines schizophrenic patients for the presence of abnormalities in proton MRS (1H-MRS) measured metabolites in two regions of the posterior fossa. Twelve schizophrenic patients and eight non- schizophrenic control subjects were studied by measuring the ratios of NAA/Cr, Cho/Cr and mI/Cr from 1H-spectra obtained from the pons and right or left cerebellum using an integrated MRI/MRS protocol. Spectra were obtained from a voxel in the pons and voxels from the left and/or right lateral cerebellum. Data were analyzed in the absorption mode and fitted to Lorentzian lineshapes using a Marquart algorithm. Significantly lower NAA/Cr ratios were found in the pons of schizophrenic patients than in the control subjects, but not in the cerebellum. This study is the first to measure brain tissue metabolites using 1H-MRS in the pons and cerebellum of schizophrenic patients. Significant alterations of 1H-MRS metabolites may suggest the involvement of the posterior fossa as a part of the pathological substrate underlying schizophrenia.

AB - Magnetic resonance spectroscopy (MRS) is a non-invasive functional imaging technique that can measure various brain tissue metabolites such as N-acetylaspartate (NAA), choline (Cho), creatine-phosphocreatine (Cr), myo- inositol (mI) and other metabolites. Morphological studies have indicated the pons and cerebellum as possible sites of abnormal functioning in schizophrenic patients. This study examines schizophrenic patients for the presence of abnormalities in proton MRS (1H-MRS) measured metabolites in two regions of the posterior fossa. Twelve schizophrenic patients and eight non- schizophrenic control subjects were studied by measuring the ratios of NAA/Cr, Cho/Cr and mI/Cr from 1H-spectra obtained from the pons and right or left cerebellum using an integrated MRI/MRS protocol. Spectra were obtained from a voxel in the pons and voxels from the left and/or right lateral cerebellum. Data were analyzed in the absorption mode and fitted to Lorentzian lineshapes using a Marquart algorithm. Significantly lower NAA/Cr ratios were found in the pons of schizophrenic patients than in the control subjects, but not in the cerebellum. This study is the first to measure brain tissue metabolites using 1H-MRS in the pons and cerebellum of schizophrenic patients. Significant alterations of 1H-MRS metabolites may suggest the involvement of the posterior fossa as a part of the pathological substrate underlying schizophrenia.

KW - Creatine-phosphocreatine

KW - Magnetic resonance imaging

KW - N-Acetylaspartate

KW - Posterior fossa

UR - http://www.scopus.com/inward/record.url?scp=17044449877&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17044449877&partnerID=8YFLogxK

U2 - 10.1016/S0925-4927(98)00043-2

DO - 10.1016/S0925-4927(98)00043-2

M3 - Article

C2 - 9870414

AN - SCOPUS:17044449877

VL - 84

SP - 17

EP - 26

JO - Psychiatry Research - Neuroimaging

JF - Psychiatry Research - Neuroimaging

SN - 0925-4927

IS - 1

ER -